Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11381
Peer-review started: September 9, 2022
First decision: September 19, 2022
Revised: September 26, 2022
Accepted: October 9, 2022
Article in press: October 9, 2022
Published online: November 6, 2022
Processing time: 48 Days and 1.2 Hours
C-reactive protein (CRP) levels are associated with ongoing organ dysfunction. It may be an Acute Physiology and Chronic Health Evaluation (APACHE) independent risk factor for mortality in medical intensive care unit (ICU) populations. However, the relationship between CRP levels at ICU admission and prolonged ICU length of stay (LoS) in gastric cancer patients after surgery has not been well defined.
In this study, our hypothesis was that CRP levels are potential biomarkers for predicting ICU LoS in GC patients after surgery. The findings were important to develop strategies to predict ICU LoS thereby improve the management of beds, staff, and identify individual patients with unexpectedly long ICU LoS.
In this study, the association between CRP levels at ICU admission and prolonged ICU LoS were evaluated.
A retrospective study was performed to quantify serum CRP levels and to establish their association with prolonged ICU LoS (longer than 72 h) in GC patients admitted to the ICU. Univariate and multivariate regression analyses were conducted, and restricted cubic spline curves with four knots (5%, 35%, 65%, 95%) were used to explore non-linearity assumptions.
A total of 408 patients were enrolled. Among them, 83 (20.3%) patients had an ICU LoS longer than 72 h. CRP levels were independently associated with the risk of prolonged ICU LoS [odds ratio (OR) 1.47, 95% confidence interval (CI) 1.00–2.17]. Restricted cubic spline analysis revealed a non-linear relationship between CRP levels and OR for the prolonged ICU LoS (P = 0.035 for non-linearity). After the cut-off of 2.6 (log transformed mg/L), the OR for prolonged ICU LoS significantly increased with CRP levels. The adjusted regression coefficient was 0.70 (95%CI 0.31–1.57, P = 0.384) for CRP levels less than 2.6, whereas it was 2.43 (95%CI 1.39–4.24, P = 0.002) for CRP levels higher than 2.6.
Among the GC patients, CRP levels at ICU admission were non-linearly associated with prolonged ICU LoS in survivors. An admission CRP level > 2.6 (log transformed mg/L) was associated with increased risk of prolonged ICU LoS.
CRP levels may still be a predictor for other unknown processes, models based on combinations of risk factors and biomarkers may be more effective in predicting prolonged ICU LoS or mortality. Future studies should explore this aspect.